SUCCESSFUL HEMATOPOIETIC RECONSTITUTION WITH TRANSPLANTATION OF ERYTHROCYTE-DEPLETED ALLOGENEIC HUMAN UMBILICAL-CORD BLOOD-CELLS IN A CHILDWITH LEUKEMIA
Rn. Pahwa et al., SUCCESSFUL HEMATOPOIETIC RECONSTITUTION WITH TRANSPLANTATION OF ERYTHROCYTE-DEPLETED ALLOGENEIC HUMAN UMBILICAL-CORD BLOOD-CELLS IN A CHILDWITH LEUKEMIA, Proceedings of the National Academy of Sciences of the United Statesof America, 91(10), 1994, pp. 4485-4488
Cord blood, a potent source of hematopoietic stem cells, has been show
n to successfully reconstitute hem atopoiesis following allogeneic tra
nsplantation in a variety of disorders. A major drawback of cord blood
has been the risk of transfusion reactions in ABO blood group incompa
tibility and drastic reduction in the stem cell pool if the cord blood
is manipulated to remove red cells prior to cryopreservation or after
thawing. This report describes an erythrocyte depletion method employ
ing 3% gelatin-induced erythrocyte sedimentation for the selective rem
oval of red cells from cord blood. The red cell-depleted fraction was
shown to be enriched in progenitor cells and in cells secreting hemato
poietic cytokines interleukin 3, granulocyte/macrophage colony-stimula
ting factor, and interleukin 6; a major source for cytokines was from
cord T cells. This preparative technique was employed to separate out
red cells from cord blood of an infant delivered by cesarean section w
ho had an 8-year-old sibling with leukemia. Histocompatibility testing
of cord cells revealed complete matching with the patient. A cord cel
l transplant of cryopreserved and thawed cells consisting of 4 x 10(7)
nucleated cells per kg was administered to the patient following myel
oablative chemotherapy. The patient's quick hematologic recovery and 9
-month disease-free period to date suggest that 3% gelatin separation
of erythrocytes is a simple method that can be successfully used for t
ransplanting cord cells for malignant/nonmalignant diseases.